Pathogenesis and Mechanisms of Injury
The development of renal dysfunction in multiple myeloma is directly related to massive proteinuria. The primary damaging factor consists of circulating and filtered excess free immunoglobulin light chains, known in clinical practice as Bence Jones protein.
The pathogenesis of renal dysfunction relies on two main mechanisms of nephrotoxicity:
- Direct toxic effect. Specific fractions of light chains exert a direct damaging effect on renal tubular epithelial cells. This disrupts cellular metabolism and reduces cell viability.
- Tubular obstruction (cast formation). Entering the acidic environment of the tubular fluid, the Bence Jones protein actively reacts with Tamm-Horsfall protein, a normal urinary glycoprotein. Their firm binding forms large, dense histological casts. These physically occlude the tubular lumen, causing intratubular obstruction and halting normal urine flow.
Morphological Findings
Morphological changes in Nephropathia myelomatosa predominantly affect the tubulointerstitial apparatus of the kidneys. The main damage mechanism involves protein casts occluding the tubular lumen, which provokes a secondary peritubular inflammatory reaction.
Macroscopic Appearance Gross examination of the kidneys does not always reveal specific features. In the early stages of the disease, the organs typically appear completely normal. However, with a prolonged disease course accompanied by nephron loss and interstitial fibrosis, the kidneys become pale and acquire a characteristic shrunken appearance.
Histological Changes (Microscopy) The key diagnostic feature on microscopy is the presence of specific casts that trigger a cascade of destructive reactions:
- Cast Characteristics: With standard staining, they appear within the tubules as dense, amorphous pinkish-blue masses. In some cases, protein aggregates form characteristic layered concentric plates. These masses critically distend the tubular lumen.
- Cellular Reaction: A specific cellular cuff forms around the protein casts; the casts are surrounded by multinucleated giant cells. These cells have a dual origin: they form either from transformed tubular epithelium itself or from migrated mononuclear phagocytes.
- Destruction of Surrounding Tissues: Epithelial cells directly contacting the casts frequently undergo necrosis. As the pathology progresses, dense protein masses literally "erode" the tubular wall.
- Interstitial Inflammation: When the tubular wall breaks down and its contents spill into the adjacent interstitium, nonspecific inflammation develops, which eventually transforms into a pronounced granulomatous reaction.
Clinical Manifestations and Associated Pathologies
Renal impairment is documented in half of patients with multiple myeloma and clinically manifests with several characteristic syndromes.
- Chronic Kidney Disease (CKD). This is the most common clinical course. The pathology develops insidiously and progresses very slowly over many months or even years, gradually impairing renal filtration function.
- Acute Kidney Injury (AKI). Unlike CKD, it is characterized by a sudden onset. The leading clinical symptom is oliguria (a sharp decrease in urine output), often associated with massive, simultaneous tubular obstruction by protein casts.
- Proteinuria. Increased urinary protein excretion occurs in 70% of myeloma patients. It is essential to carefully assess the nature of proteinuria. If the urine is dominated not by light chains but by pronounced albuminuria (loss of albumin), it indicates the development of concurrent renal filter pathologies.
Associated Processes In addition to classical cast nephropathy (myeloma kidney), multiple myeloma can be accompanied by other severe renal lesions. These include secondary AL amyloidosis, membranous nephropathy, and specific glomerulopathy known as light chain deposition disease.